Saxon Interests, Inc. Anavex Life Sciences Corp. Transaction History
Saxon Interests, Inc.
- $213 Million
- Q3 2024
A detailed history of Saxon Interests, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Saxon Interests, Inc. holds 27,376 shares of AVXL stock, worth $156,590. This represents 0.07% of its overall portfolio holdings.
Number of Shares
27,376
Previous 26,699
2.54%
Holding current value
$156,590
Previous $112,000
38.39%
% of portfolio
0.07%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
154Shares Held
26.6MCall Options Held
674KPut Options Held
811K-
Black Rock Inc. New York, NY6.39MShares$36.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.55MShares$26 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$21.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.83MShares$10.5 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.01MShares$5.79 Million0.01% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $446M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...